Autumn 1995



h Racial differences in the prevalence of microalbuminuria in hypertension (Oct 95 AJKD)
h Diuretics, beta-blockers , and the risk for sudden cardiac death in hypertensive patients (Oct 95 AIM)
h Effects of hypertension and dyslipidemia on the decline in renal function (Oct 95 HYP)
h Combined renal effects of overweight and hypertension (Oct 95 HYP)
h Cyclosporine impairs vasodilatation without increased sympathetic activity in humans (Oct 95 HYP)
h Prevalence of moderate hyperhomocysteinemia in patients with early- onset venous and arterial occlusive disease (Nov 95 AIM)
h Blood pressure control, proteinuria and the progression of renal disease (Nov 95 AIM)
h Autonomic nervous function in non-dipper essential hypertensive subjects (Nov 95 HYP)
h Suppressing sympathetic activation in congestive heart failure (Nov 95 HYP)
h State of the Market: A review of ambulatory blood pressure monitoring devices (Nov 95 HYP)
h A randomized controlled trial of stress reduction for hypertension in older African Americans (Nov 95 HYP)
h Enhanced levels of tissue-type plasminogen activator in borderline hypertension (Nov 95 HYP)
h Assessment of renal resistance index after captopril test by Doppler in essential and renovascular hypertension (Nov 95 KI)
h Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension (Nov 95 NEJM)
h Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? (Dec 95 HYP)
h Combinations of potassium, calcium, and magnesium supplements in hypertension (Dec 95 HYP)
h Treatment of renovascular hypertension: One year results of renal angioplasty (Dec 95 KI)

Dialysis, Chronic Renal Failure

d Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn (Oct 95 ARRT)
d Heparinization for routine hemodialysis (Oct 95 ARRT)
d Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance hemodialysis (Oct 95 AJKD)
d Peritonitis rate: Traditional versus low calcium dialysate (Oct 95 AJKD)
d Constant site (buttonhole) method of needle insertion for hemodialysis (Oct 95 DT)
d Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers (Oct 95 JASN)
d Symptomatic hypercalcemia in a diabetic patient undergoing CAPD: Value of bone biopsy in the diagnosis and management (Nov 95 AJKD)
d The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism (Nov 95 AJKD)
d Cannulation camp: Basic needle cannulation training for dialysis staff (Nov 95 DT)
d Differences in dynamics of parathyroid hormone secretion in hemodialysis patients with marked secondary hyperparathyroidism (Nov 95 JASN)
d Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism (Nov 95 KI)
d Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure (Dec 95 AJKD)
d Blood pressure influences the occurrence of complex ventricular arrhythmia in hemodialysis patients (Dec 95 HYP)
d Correcting acidosis in hemodialysis: Effect on phosphate clearance and calcification risk (Dec 95 JASN)
d Anastomotic intimal hyperplasia in prosthetic AV fistulas for hemodialysis is associated with initial high flow velocity and not with mismatch in elastic properties (Dec 95 JASN)
d Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes (Dec 95 JASN)
d Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies (Dec 95 KI)
d HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis (Dec 95 KI)

Clinical Nephrology

c Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus (Oct 95 AJKD)
c Interventions in clinical acute renal failure: What are the Data? (REVIEW) (Oct 95 AJKD)
c Compulsive water drinking in the setting of anticholinergic drug use: an unrecognized cause of chronic renal failure (Oct 95 AJKD)
c Escherichia coli O157:H7 infection in humans (REVIEW) (Nov 95 AIM)
c High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure (Oct 95 KI)
c Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography (Oct 95 KI)
c Nephrology Forum -- Acute myeloma kidney (REVIEW) (Oct 95 KI)
c A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis (Oct 95 LAN)
c Nabumetone-associated interstitial nephritis (Oct 95 PHA)
c A randomized, placebo-controlled, multicenter trial evaluating alternate- day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy (Nov 95 AJKD)
c A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy (Nov 95 KI)
c The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy (Dec 95 AJKD)
c Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations (Dec 95 AmJM)
c The role of antineutrophilic cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis (Dec 95 AIM)
c Urinary excretion of beta-2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy (Dec 95 JASN)
c U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin gene polymorphism with microalbuminuria in NIDDM (Dec 95 KI)
c A long-term prospective controlled study of analgesic abuse in Belgium (Dec 95 KI)

UP Use back arrow on your browser to go back to HDCN home page (faster) or click on the arrow.